Ceigall India Share Price Rises 1.26% to Rs 317.15 After Winning Rs 225 Crore HPSIDC Order for Bulk Drug Park at Una, Himachal Pradesh
- August 21, 2026
- Posted by: Neeraj Pandey
- Category: Market
CEIGALL: Rs 317.15 (+1.26%). Order: Rs 225 cr from HPSIDC. Project: Bulk Drug Park Phase I, Una HP. Roads, drains, bridge, fencing. Aug 21, 2026.
Quick Answer
Ceigall India share price rose 1.26% to Rs 317.15 on August 21, 2026, after receiving a Letter of Award worth Rs 225 crore from HPSIDC for Phase I infrastructure development at the Bulk Drug Park in Una District, Himachal Pradesh.
What Is the Ceigall India Rs 225 Crore Order Win?
Ceigall India received a Letter of Award (LOA) from Himachal Pradesh State Industrial Development Corporation Limited (HPSIDC) for a work order worth Rs 225 crore. The project involves development of a Bulk Drug Park at Una District, Una, Himachal Pradesh. The scope of work includes formation cutting, construction of internal roads, storm water drains, bridge, and fencing for Phase I of the park. This is an infrastructure development assignment that falls squarely within Ceigall India’s core competence of civil and infrastructure construction.
Ceigall India share price rose 1.26% to Rs 317.15 on August 21, 2026, on the back of this order win announcement. The intraday high was Rs 318.90 and the intraday low was Rs 312.60.
Click Here – Get Free Investment Predictions
Order Details and Significance
| Parameter | Detail |
|---|---|
| Client | HP State Industrial Development Corporation (HPSIDC) |
| Order Value | Rs 225 crore |
| Project | Bulk Drug Park — Una District, Himachal Pradesh |
| Scope | Formation cutting, roads, storm drains, bridge, fencing (Phase I) |
| Document Type | Letter of Award (LOA) |
| CMP (21 Aug 2026) | Rs 317.15 (+1.26%) |
| Intraday High | Rs 318.90 |
| Intraday Low | Rs 312.60 |
What Is the Himachal Pradesh Bulk Drug Park?
The Bulk Drug Park at Una, Himachal Pradesh is a government-backed pharmaceutical manufacturing cluster designed to attract API (Active Pharmaceutical Ingredient) manufacturers to a single location with shared infrastructure. The Indian government has been promoting bulk drug parks under the PLI (Production Linked Incentive) scheme to reduce India’s dependence on API imports, particularly from China. Ceigall India’s order to develop the Phase I infrastructure of this park positions it at the intersection of the government’s infrastructure push and the pharmaceutical self-reliance programme.
Screen Ceigall India on Univest Screener for Order Book and Fundamentals
Ceigall India: Business Overview and Order Book
Ceigall India is an infrastructure construction company engaged in the development of highways, bridges, flyovers, and industrial infrastructure across India. A Rs 225 crore order win from a state government entity like HPSIDC adds to the company’s order book and provides revenue visibility for the next 12-24 months depending on the project execution timeline.
The volume today at 6,501 shares is significantly below the five-day average of 70,392 shares — a 90.76% decrease — suggesting the order win has not yet triggered large-scale volume-driven buying and the price move is based on smaller investor activity. This can sometimes indicate more upside as larger institutional participants catch up with the news.
Download the Univest iOS App or Univest Android App to track Ceigall India share price and order win announcements live.
Conclusion
Ceigall India share price rose 1.26% to Rs 317.15 on August 21, 2026, after receiving a Rs 225 crore Letter of Award from HPSIDC for Phase I infrastructure at the Bulk Drug Park in Una, Himachal Pradesh. The order adds revenue visibility and aligns with India’s pharmaceutical infrastructure development agenda. Verify all data on NSE and BSE before making any investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Ceigall India share price up today?
Ans. Ceigall India share price rose 1.26% to Rs 317.15 on August 21, 2026, after receiving a Letter of Award (LOA) worth Rs 225 crore from HPSIDC for development of a Bulk Drug Park at Una District in Himachal Pradesh.
What is the Ceigall India Rs 225 crore order?
Ans. Ceigall India received a LOA from Himachal Pradesh State Industrial Development Corporation (HPSIDC) for infrastructure development at a Bulk Drug Park in Una District. The Rs 225 crore Phase I scope includes formation cutting, internal roads, storm drains, a bridge, and fencing.
What is Ceigall India share price today on August 21, 2026?
Ans. Ceigall India was trading at Rs 317.15 on August 21, 2026, up Rs 3.95 or 1.26% from the previous close. Intraday high was Rs 318.90 and intraday low was Rs 312.60.
What is the Himachal Pradesh Bulk Drug Park at Una?
Ans. The Bulk Drug Park at Una, Himachal Pradesh is a government-supported pharmaceutical cluster aimed at attracting API manufacturers. It is part of India’s PLI scheme to develop domestic API manufacturing capacity and reduce dependence on imports. Ceigall India won the Phase I civil infrastructure contract.
What is Ceigall India’s business?
Ans. Ceigall India is an infrastructure construction company that builds highways, bridges, flyovers, and industrial infrastructure. The Rs 225 crore HPSIDC order for the Bulk Drug Park adds to its government and institutional order book.
Is Ceigall India a good buy after the order win?
Ans. This article is for educational purposes and is not investment advice. The order win is a positive revenue visibility signal, but investment decisions should be based on Ceigall India’s full order book, margins, debt levels, and execution track record. Consult a SEBI-registered advisor.
